Literature DB >> 20016218

Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004).

Silvia Koton1, David Tanne, Manfred S Green, Natan M Bornstein.   

Abstract

BACKGROUND: Despite declining age-adjusted stroke mortality rates, the disease remains the third most common cause of death in Israel. Based on a national survey, we examined mortality rates during the first 3 years after a first-ever acute ischemic stroke (IS) and the major predictors of short-term (1 month) and long-term (3 years) mortality.
METHODS: In the National Acute Stroke Israeli Survey (NASIS 2004), data were collected on all hospitalized stroke patients in Israel during a 2-month period. Mortality rates for first-ever IS were assessed at 1 month and 3 years and predictors of death were evaluated using the Cox proportional hazard model.
RESULTS: A total of 1,079 first-ever IS patients were included. Survival data were complete for over 99% of patients. Cumulative mortality rates were 9.9% at 1 month and 31.1% at 3 years. Of the survivors at 1 month, 23.5% did not survive for 3 years. At 1 month, the hazard ratio (HR) for death significantly increased with stroke severity. One-month mortality was also associated with a decreased level of consciousness (HR 2.9, 95% CI 1.7-5.1), total anterior circulation infarction (TACI); HR 4.9, 95% CI 1.6-15.2), temperature on admission (HR 1.5, 95% CI 1.1-2.1 per 1 degrees C), age (HR 1.04, 95% CI 1.02-1.07 per year) and glucose levels on admission (HR 1.003, 95% CI 1.001-1.006 per 1 mg/dl). Age-adjusted proportions of diabetes and chronic heart failure were considerably higher in the deceased compared with survivors at 3 years (48 vs. 38 and 21 vs. 9%, respectively). In the multivariate survival analyses, predictors of death at 1 month also predicted death at 3 years; however, history of dementia (HR 1.5, 95% CI 1.0-2.4), diabetes (HR 1.6, 95% CI 1.0-2.4), peripheral artery disease (HR 1.7, 95% CI 1.1-2.8), chronic heart failure (HR 1.6, 95% CI 1.1-2.4) and malignancy (HR 1.7, 95% CI 1.1-2.7) were additional predictors of long-term mortality for patients surviving the first month after stroke.
CONCLUSIONS: Approximately one third of patients did not survive 3 years after the first-ever IS. While age and markers of severe stroke were the major predictors of death at 1 month, comorbidities and variables associated with atherosclerotic vascular disease predicted long-term mortality. Improved control of these factors can potentially reduce long-term mortality in stroke victims. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 20016218     DOI: 10.1159/000264826

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  24 in total

1.  CHA(2)DS(2)-VASc score and prognosis in ischemic strokes with atrial fibrillation.

Authors:  Eva Giralt-Steinhauer; Elisa Cuadrado-Godia; Ángel Ois; Jordi Jiménez-Conde; Ana Rodríguez-Campello; Lluis Planellas; Sara Jimena-García; Miguel Ángel Rubio; Jaume Roquer-González
Journal:  J Neurol       Date:  2011-10-08       Impact factor: 4.849

2.  Endovascular Treatment Decisions in Patients with M2 Segment MCA Occlusions.

Authors:  M Almekhlafi; J M Ospel; G Saposnik; N Kashani; A Demchuk; M D Hill; M Goyal; B K Menon
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-30       Impact factor: 3.825

3.  Brain natriuretic peptide predicts functional outcome in ischemic stroke.

Authors:  Natalia S Rost; Alessandro Biffi; Lisa Cloonan; John Chorba; Peter Kelly; David Greer; Patrick Ellinor; Karen L Furie
Journal:  Stroke       Date:  2011-11-23       Impact factor: 7.914

4.  Immune-inflammatory, oxidative stress and biochemical biomarkers predict short-term acute ischemic stroke death.

Authors:  Edna Maria Vissoci Reiche; Jair Roberto Gelinksi; Daniela Frizon Alfieri; Tamires Flauzino; Marcio Francisco Lehmann; Maria Caroline Martins de Araújo; Marcell Alysson Batisti Lozovoy; Andrea Name Colado Simão; Elaine Regina Delicato de Almeida; Michael Maes
Journal:  Metab Brain Dis       Date:  2019-03-14       Impact factor: 3.584

5.  Association of age and admission mean arterial blood pressure in patients with stroke-data from a national stroke registry.

Authors:  Yoav Eizenberg; Silvia Koton; David Tanne; Ehud Grossman
Journal:  Hypertens Res       Date:  2016-01-07       Impact factor: 3.872

6.  Analysis of the risk factors for the short-term prognosis of acute ischemic stroke.

Authors:  Jin Liang; Wenbo Liu; Jianping Sun; Xinyi Gu; Qiang Ma; Weijun Tong
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Pre admission treatment with Beta-blockers in hypertensive patients with acute stroke and 3-month outcome-Data from a national stroke registry.

Authors:  Yoav Eizenberg; Ehud Grossman; David Tanne; Silvia Koton
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-09       Impact factor: 3.738

8.  Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume.

Authors:  Heidi Ormstad; Hans Christian Dalsbotten Aass; Niels Lund-Sørensen; Karl-Friedrich Amthor; Leif Sandvik
Journal:  J Neurol       Date:  2011-03-20       Impact factor: 4.849

9.  Carotid intima media thickness measurements coupled with stroke severity strongly predict short-term outcome in patients with acute ischemic stroke: a machine learning study.

Authors:  Ana Lucia Cruz Fürstenberger Lehmann; Daniela Frizon Alfieri; Maria Caroline Martins de Araújo; Emanuelle Roberto Trevisani; Maisa Rocha Nagao; Francisco Spessatto Pesente; Jair Roberto Gelinski; Leonardo Bodner de Freitas; Tamires Flauzino; Márcio Francisco Lehmann; Marcell Alysson Batisti Lozovoy; José Wander Breganó; Andréa Name Colado Simão; Michael Maes; Edna Maria Vissoci Reiche
Journal:  Metab Brain Dis       Date:  2021-08-04       Impact factor: 3.584

10.  Short-term and long-term stroke survival: the belgrade prognostic study.

Authors:  Sanja Medic; Ljiljana Beslac-Bumbasirevic; Darija Kisic-Tepavcevic; Tatjana Pekmezovic
Journal:  J Clin Neurol       Date:  2013-01-03       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.